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The relentless progression of many renal diseases to end-
stage renal failure after an apparently transient initial insult
remains an enigma that continues to fascinate nephrologists.
The "hyperfiltration" hypothesis based on the rat remnant
kidney model of nephron ablation provided much of the intel-
lectual stimulus to the study of glomerular injury and scarring in
the progression of renal disease [1]. While this may have some
relevance to human renal disease progression [2], the early
work of Risdon et al [3], Schainuck et a! [4] and Bohle et al [5]
has made it clear that, perhaps paradoxically, it is the degree of
tubulointerstitial pathology that correlates most closely with
declining renal function even in classical "glomerular" dis-
eases. Belated recognition has now given rise to a new interest
in the pathological processes occurring in the tubulointerstitial
compartment of the diseased kidney. In this paper, we review
briefly the histopathological evidence for the involvement of the
tubulointerstitium in progressive renal disease and discuss
potential mechanisms for tubulointerstitial injury. We also
discuss pathways via which tubulointerstitial disease may lead
to loss of glomerular function and propose a unifying hypothesis
which links the two, taking into account much of the known
experimental evidence at present.
Tubulointerstitial changes correlate with renal disease
progression
In 1968, while attempting to find a histological correlate for
functional renal impairment in patients with chronic glomeru-
Ionephritis, Risdon and his colleagues arrived at what appeared
to be an anomalous finding: a positive correlation between
tubular atrophy and a decline in glomerular filtration rate
(GFR), but no significant correlation between glomerular dam-
age and GFR [3]. Soon afterwards, Schainuck and Striker et al
extended this observation with detailed studies of renal function
in patients with a variety of nephropathies [4, 6]. Once again,
they found that impaired renal function (including inulin clear-
ance, renal plasma flow rate, concentrating ability and ammo-
nium excretion) correlated most closely with tubulointerstitial
histological changes.
However, it was the careful and detailed histomorphometric
studies of Bohle and colleagues over the last 15 years that put
the issue largely beyond doubt. By studying large numbers of
renal biopsies of specific diseases including classical "glomer-
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ular" diseases, they were able to show that the appearance of
the tubulointerstitial compartment in the initial biopsy was the
main histological predictor of whether renal function would be
preserved or lost [6]. Thus, in extreme cases relatively normal
glomerular appearances could co-exist with a severely impaired
GFR while highly abnormal glomerular appearances could
co-exist with a normal GFR [7]. This apparent anomaly became
explicable, however, if concomitant tubulointerstitial changes
were also taken into account. Two other relevant factors should
also be considered: the age of the patient and the existence of
potentially "reversible" increases in interstitial volume. It is
well-known that older patients tend to have more interstitial
fibrosis in association with decrements in GFR; the cause of this
is unknown [8]. Also, interstitial volume may be expanded in
inflammation by edema or infiltrating cells without matrix
deposition. This expansion could thus resolve spontaneously or
in response to treatment, and may provide an explanation for
the negative findings of Bennett, Walker and Kincaid-Smith
who were unable to find a correlation between the increase in
interstitial volume and decline in GFR when serial biopsies of
patients with IgA nephropathy were examined [9].
Potential mechanisms of tubulointerstitial injury
How do we reconcile the fact that various diseases which
primarily affect glomeruli appear to set in train secondary
processes that affect the tubulointerstitium resulting in tubular
atrophy, interstitial fibrosis and interstitial mononuclear cell
infiltrates? For convenience, our current knowledge can be
discussed under several headings: microvascular injury, tubular
cell injury, tubular cell-inflammatory cell interactions, altered
fibroblastic phenotype and tubular cell-fibroblast "cross-talk."
Microvascular injury
Direct histomorphometry of ultrathin sections of renal biop-
sies taken from human kidneys with glomerular diseases has
demonstrated obliteration of the post-glomerular peritubular
capillary network in these kidneys [10]. The functional conse-
quence of this would be tubular cell ischemia [11]. Renal
oxygen consumption is already high at rest and may be further
increased by adaptive processes in the remnant kidney [12, 13].
Thus, the net result of diminished oxygen delivery and in-
creased oxygen demand would logically be tubular hypoxia and
injury.
The mechanisms which lead to a loss of the post-glomerular
circulation are not known, but one possibility is systemic
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hypertension since hypertension is a common accompaniment
of most human renal diseases. It should be noted that tubuloin-
terstitial injury is a prominent histological feature of the rem-
nant kidney [2, 14] but that this finding is absent if blood
pressure is not elevated [14]. Several studies both in rats [15]
and humans [16] have shown that better control of systemic
blood pressure leads to a slowing of the rate of decline of GFR
in the diseased kidney. In the remnant kidney, both afferent and
efferent arterioles are dilated as part of the adaptive response to
increased glomerular blood flow [17]. Thus, it is possible that
systemic blood pressure results not only in "glomerular" but
also "post-glomerular" hypertension. Certainly, it seems likely
that any sustained increase in peritubular capillary pressure
could adversely affect endothelial, interstitial and tubular cell
function. For example, in a rat remnant kidney model, tubular
expression of PDGF in the collecting ducts was increased with
poorly controlled blood pressure but was reduced with good
blood pressure control [18]. PDGF is not only a potent mitogen
for interstitial fibroblasts [19] but is also a very potent vasocon-
strictor substance [201. Thus, the elaboration of various vaso-
active substances from endothelial (such as endothelin) [21],
interstitial (such as adenosine) [22] and tubular cells (PDGF,
angiotensin II, endothelin) [19, 23, 24] may result both in
vasoconstriction and increased interstitial fibrosis. This would
result ultimately in obliteration of the peritubular capillary
network. Bohle has suggested that in the early stages, this rise
in post-glomerular resistance could result in glomerular enlarge-
ment, but the mechanism for this was not stated [10]. Possibly
glomerular capillary distension could lead to hypertrophy of the
glomerulus. Since hypertrophic glomeruli are thought more
likely to sclerose [25], it seems plausible that the obliteration of
the post-glomerular capillary network may be one way in which
glomerular hypertrophy and sclerosis may be linked.
The recently demonstrated protective effect of converting
enzyme inhibition on the tubulointerstitial component of the
fibrosis observed in the remnant kidney may well be mediated
by an improvement in the post-glomerular circulation (due to
efferent arteriolar dilatation) provided that systemic blood
pressure is reduced [18]. If it is not, peritubular injury could
well be aggravated.
Tubular cell injury
Hypermetabolism. Renal oxygen consumption is largely de-
termined by the rate of tubular transport, and in many forms of
renal disease with hypertrophied tubules this is increased [12].
Any factors that might increase sodium reabsorption, for ex-
ample high protein diets, will further increase oxygen consump-
tion. Several authors have suggested that increased oxygen
consumption by the remnant kidney might itself be damaging.
Two possible mechanisms have been proposed: increased am-
moniagenesis and increased generation of reactive oxygen
species. Increased ammoniagenesis has been linked with in-
creased oxygen consumption in the surviving nephrons of
remnant kidneys [26]. The ammonia generated is thought to
then activate the third component of complement (C3) which
then leads to activation of the alternative complement cascade
[27]. This in turn could lead to the influx of inflammatory cells,
the elaboration of inflammatory mediators and increased colla-
gen synthesis by tubular cells [28]. C3 could also be synthesized
locally by tubular cells and its production upregiilated by
interleukin 2 secreted locally by T cells [29], thus further fueling
the process. Against this hypothesis is the fact that ammonia
concentrations increase to very high concentrations normally in
the renal medulla without causing injury. However, Clark and
his co-workers have shown experimentally that a hyperosmolar
milieu is able to protect against injury triggered by increased
ammonia concentrations [30].
Increased oxygen consumption may also lead to the in-
creased generation of reactive oxygen species by tubular cells
[31, 32]. However, normal anti-oxidant defense mechanisms
may be adequate to prevent significant oxidative injury unless a
further stress, such as a high protein diet, is imposed on the
remnant kidney [32, 33]. Indeed, the dietary depletion of
antioxidants imposed on weanling rats is sufficient in itself to
lead to proteinuria, a decreased GFR and a tubulointerstitial
infiltrate [34]. Reactive oxygen species may also up-regulate
collagen gene expression by tubular cells as they do in fibro-
blasts [35].
Because tubular atrophy is the rule in advanced tubulointer-
stitial disease, it is reasonable to speculate that the adaptive
processes described above occur early, that is, where tubular
hypertrophy is observed [36], but that this gives way to atrophy
as the tubular cells become damaged by ischemia or toxic
molecules.
Filtration of "noxious" molecules. Several studies have
shown that proteinuria per se is an independent risk factor for
the decline in renal function in proteinuric states [37, 38].
Moreover, recent studies suggest that the reduction in protein-
uria itself might be beneficial in reducing the rate of decline in
GFR [15]. Previously, in two established rat models of glomer-
ulosclerosis, that is, puromycin aminonucleoside and adriamy-
cm treated rats, serial micropuncture studies of the same
glomeruli showed that the progressive loss of glomerular func-
tion was independent of any change in glomerular capillary
pressures which remained normal throughout [39]. Moreover,
the beneficial effect of captopril in reducing glomerulosclerosis
was independent of its effect on glomerular hemodynamics [39].
It is of interest also that in both these models, tubulointerstitial
changes precede the development of glomerulosclerosis [38].
This finding has been extended recently by the observation that
enalapril reduces tubulointerstitial damage in the rat remnant
kidney model independently of its effect on systemic blood
pressure [18]. The exact mechanism for this beneficial effect of
angiotensin-converting enzyme inhibitors is unclear, but apart
from the protective effect on the postglomerular circulation
described above, it could involve an effect in reducing protein-
uria.
Apart from albumin, a variety of circulating macromolecules
may also be filtered in nephrosis. These include immunoglobu-
lins, haptoglobin, lipoproteins, transferrin and complement
(Table 1). In addition, red blood cells are commonly filtered in
glomerular diseases.
Several groups have attempted to investigate the potential
tubular toxicity of filtered albumin. Eddy developed a model of
"protein-overload proteinuria" by injecting bovine albumin
into rats. Heavy proteinuria was accompanied by proximal
tubular regeneration (neo-expression of vimentin) and an inter-
stitial mononuclear cell infiltrate. Surprisingly, in view of the
heterologous albumin used, there was no evidence of immune
complex deposition in the glomeruli, tubules or interstitium.
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Table 1. Relation of filtered substances to tubulointerstitial injury
Disease model Nature of tubulointerstitial injury
Overload proteinuria (40] Increased vimentin expression in proximal tubules due to endocytic protein uptake;
tubulointerstitial disease.
Heymann nephritis [41] Lysozymuria due to failure of normal tubular uptake of filtered lysozyme; proximal
tubular injury.
Myeloma (light chain proteinuna) [42] Light-chain-induced. Impaired transport function in proximal tubule and
tubulointerstitial disease.
Puromycin aminonucleoside nephropathy [43] Evidence of tubulointerstitial damage possibly due to filtered proteins.
Complementuria [44] Histological damage to proximal tubules(?) secondary to activation of filtered
complement proteins by brush border membrane.
Nephrotoxic serum nephritis transferrinuria Postulated iron release into tubular luman injuries tubular cells (?iron-catalyzed
[451 generation of hydroxyl ions); attenuated by iron deficiency.
Erythrocyte constituents [46] Hem-induced tubular damage possibly mediated by iron-dependent free radical
formation.
Hyperlipoproteinemia [47] Reabsorption of filtered lipoproteins by tubular cells induces tubular injury.
Moreover, T cell depletion did not alter the course of disease,
implying that tubulointerstitial injury in this model was not
primarily T cell-mediated. The mechanism by which albumin is
damaging to proximal tubular cells, however, remains unclear;
Eddy speculated that the increased trafficking and degradation
of albumin in these cells may lead to the release of degradative
enzymes into the interstitium [40].
Taking a different approach, Schreiner has found that the
urine of proteinuric rats and humans contains a yet unidentified
but specific macrophage lipid chemotactic factor [48]. In vitro,
cultured rat tubular cells also produce the same factor when
exposed to high concentrations of albumin [49]. Thus, in this
model filtered albumin may lead to secondary immune injury
via the production of chemotactic factors by the "injured"
tubule [48].
In spite of the attractiveness of these animal models, albu-
minuria per se cannot be damaging in human disease as no
tubulointerstitial injury is seen in minimal change disease in
spite of heavy albuminuria. Nevertheless, it is clear that certain
pathological proteins such as monoclonal light chains can
impair proximal tubular transport and lead to tubulointerstitial
injury [42, 501. Thus, the potential toxicity of other filtered
proteins remains to be fully elucidated in relevant disease
models.
Tubular cell-immune cell interaction
We have already referred to the possibility that primary
tubular injury that is non-immune may result in an interstitial
immune infiltrate via the production of tubular-derived chemo-
tactic factors. Several other disease models characterized by
primary non-immune tubular injury also point to a different
consequence of injury: tubular cells can be induced to present
antigen. For example, ischemic acute tubular necrosis in the
mouse induces early Class I antigen expression in tubular cells
and late Class II expression by tubule and interstitial cells [51].
In another model, a known tubular toxin, mercuric chloride,
given at low dose induces early Class II expression by tubular
cells followed later by a cell infiltrate and immune glomerular
deposits [52]. However, both Class II expression and lympho-
cytic infiltration were interferon-gamma (or T cell) dependent as
shown by blocking experiments with antibody to interferon-
gamma [52]. The early pathological significance of Class II
MHC expression by tubular cells in vivo has been emphasized
in both animal [53] and human [54] studies. Early expression of
Class II molecules on renal tubular cells prior to the onset of
glomerular inflammation and proteinuria could be demonstrated
in a mouse lupus model, the MRL-lpr model [53]. Such expres-
sion was localized to tubules with heavy surrounding mononu-
clear cell infiltrates [53]. In a few human subjects who under-
went serial renal biopsies, Muller was able to demonstrate early
aberrant tubular expression of HLA DQ, HLA DP and ICAM-l
prior to the development of an interstitial cell infiltrate and
significant fibrosis [54].
Proximal tubular cells can be induced to express Class II
antigens in vivo [55] and in vitro [56] by interferon-gamma. They
can also be induced to express ICAM-1 by interferon-gamma,
IL-l and TNF-alpha [57]. In culture, they can function effec-
tively as antigen-presenting cells to MHC-restricted antigen-
specific T cells [58]. However, the in vivo relevance of these
findings is unclear since in a transgenic kidney transplant
model, high levels of tubular class II molecule expression could
not initiate immune injury within a six month follow-up period
[59]. Normal immune interaction between antigen-presenting
cells and responder T cells requires the co-expression of both
ICAM-l and Class II molecules, especially if expression of the
latter is low [60]. When induced, ICAM-1 has been found on the
apical tubular cell surface whereas Class II antigens are located
basolaterally [55, 61]. Whether ICAM-1 can be relocated to the
basolateral surface in the intact tubule during antigen recogni-
tion is not known. If, however, there is prior sublethal tubular
cell injury such as with ischemia, rapid redistribution of surface
molecules such as ICAM- 1 could occur to facilitate tubular
cell-T cell interactions [62].
Clearly, a close interaction between tubular cells and immune
cells is envisaged. We would argue that a primary glomerular
injury which may be immune or non-immune could lead to
non-immune tubular cell injury, for example due to ischemia or
proteinuria. This could lead to the activation or expansion of
the sparse normal resident population of immune cells and
promote the influx of new cells initially in response to tubular-
derived cytokines such as MCP-l and IL-8 [63]. Class II
expression and ICAM- 1 expression would be augmented fur-
ther through the secretion of lymphokines, thus enabling tubu-
lar cells to present antigen and so magnifying the immune
process [64]. Neo-antigens in these schemes would be derived
from filtered proteins or be "exposed" by ischemia [38, 65].
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VASCULAR EVENTS
PRIMARY GLOMERULAR DISEASE
TUBULAR EVENTS
FILTRATION EVENTS
Afferent and efferent
arteriolar dilation
in presence of systemic
hypertension
Adaptation of tubular
function with increased
oxygen consumption
in surviving nephrons
Increased glomerular
capillary permeability
to macromolecules
Transmission of elevated
hydraulic pressure to
peritubular capillary network
Hypertensive microvascular
injury with narrowing
and obliteration of peritubular
capillaries and tubular ischemia
Increased ammoniagenesis
Increased relative oxygen
species
Complement
activation
Delivery of "noxious"
molecules into tubular
fluid
Reabsorption of
filtered macromolecules
J
CHRONIC TUBULAR INJURY
/ Release of growth factors and cytokines
Disruption of balance
between synthesis and
degradation of cellular
constituents
Interstitial fibroblast
proliferation with increased
deposition of extracellular
matrix material
Chemo-attraction
and proliferation of
infiltrating cells
Tubular Atrophy
Interstitial Fibrosis
Interstitial infiltrate
OBLITERATION OF POST-GLOMERULAR
INTERSTITIAL CAPILLARY NETWORK
Secondary elevation
of glomerular capillary pressure
PROGRESSIVE LOSS OF RENAL FUNCTION
Fibroblasts are not the only source of interstitial collagens.
Although tubular cells normally synthesize collagen types IV
and V (basement membrane), under certain conditions they
may also secrete interstitial collagens: types I and III. In a
mouse model of autoimmune interstitial nephritis, a T cell-
derived tubular antigen-binding protein could be shown to
specifically down-regulate transcription of type IV collagen by
tubular cells [66]. Simultaneously, type I collagen synthesis
appeared to be up-regulated in vivo by other factors [66]. This
study illustrates the close interaction between tubular cells and
immune cells. Just as tubular derived factors may modulate
immune cell function, factors derived from immune cells may
modulate tubule function [67].
Fig. 1. Hypothetical sequence of events
leading from primary glomerular disease
through tubulointerstitial injury o progressive
loss of renal function. (Reproduced by
permission of Eur J Clin Invest [79]).
An altered fibroblast phenotype
Several groups have now demonstrated that fibroblasts taken
from sites of inflammation and fibrosis from several organs
appear to show a stable altered phenotype in vitro [68]. In the
kidney, Rodemann and Muller have shown in a limited number
of cases that human fibroblasts taken from fibrotic kidneys
(FKF cells) are hyperproliferative and produce more collagen
than normal renal fibroblasts (NKF) [69]. FKF cells also
produce a novel protein, yet to be fully characterized, which
has been named "fibrosin." By clonal culture analysis, they
have also shown that FKF cells are comprised of more "mitot-
ic" than "post-mitotic" cells, implying activation of a putative
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fibroblast stem cell population [69]. Intriguingly, they reported
that FKF-conditioned medium could make normal human kid-
ney and skin fibroblasts hyperproliferative [69]. The latter
observation suggests that FKF cells may be involved in an
autocnne loop where an initial stimulus has switched on auto-
crine production of a growth factor which then continues to
stimulate its own production by positive feedback. Examples
where this has been shown include platelet-derived growth
factor (PDGF) in mesangial cells [70] and acidic-fibroblast
growth factor (a-FGF) in polycystic human kidney fibroblasts
[71]. An alternative explanation for the stable alteration in
phenotype is a somatic mutation. There is evidence that smooth
muscle cells derived from human atherosclerotic plaques show
hyperproliferative activity, enhanced myc proto-oncogene ex-
pression and transforming activity [72]. Clearly, a somatic
mutation could account for this without the need to invoke
gross chromosomal changes or malignant transformation. For
the time being, however, the exact mechanism for the observed
alteration in phenotype, whether genetic or epigenetic, must
remain an open question. Nevertheless, the induction of a
stable hyperproliferative phenotype in renal interstitial fibro-
blasts taken from fibrotic kidneys goes some way to explain the
progressive nature of renal disease.
Tubular cell-fibroblast "cross-talk"
Increasingly, tubular cells have been found to be a rich
source of a variety of molecules including chemotactic cyto-
kines such as MCP-l and IL-8 [63], multifunctional pleiotropic
cytokines such as IL-6 [73] and TNF-a [56], complement
components such as C3 [29], growth factors such as PDGF,
IGF- 1, TGF-f3, EGF, GM-CSF [73—75] and vasoactive peptides
such as endothelin, angiotensin II [23, 24, 76]. Although the
physiological role of most or all of these factors in the normal
kidney is unknown, it can be assumed that tubular cell "dys-
function," for example secondary to proteinuria, may lead to
dysregulation of the synthesis and secretion of these factors,
further contributing to tubulointerstitial injury by their actions
on interstitial fibroblasts and immune cells. One such paracrine
loop was demonstrated by in vitro studies of rabbit kidney [19,
77]. In culture, inner medullary collecting duct (IMCD) cells
secreted a variety of growth factors including PDGF, IGF-1 and
TGF-/3. However, when IMCD cells and papillary fibroblasts
were co-cultured, papillary fibroblast proliferation could be
blocked only by antibodies to PDGF but not IGF-l. Further-
more, the absence of an identical loop in the cortex suggested
that this loop was specific to the inner medulla. It remains
highly likely that other similar paracrine loops operate at
different segments of the nephron but remain to be discovered.
Interestingly, increased PDGF-receptor sites on interstitital
fibroblasts have been demonstrated in transplanted human
kidneys undergoing chronic rejection [78], implying a role for
PDGF in the tubulointerstitial pathology of this disease.
Tubulointerstitial injury and loss of glomerular function: A
possible sequence of events
In this review, we have attempted to show that there is now
sufficient experimental evidence to support our contention that
an acute primary glomerular insult may set into train secondary
chronic tubulointerstitial disease processes which gradually
lead to the loss of glomerular function. Figure 1 summarises a
possible sequence of events according to the evidence so far.
The complexity of the pathways envisaged and our relative
ignorance of their finer points imply that only a limited under-
standing of these pathological processes is possible at this
stage. For the moment, however, the seemingly paradoxical
loss of GFR which correlates with tubulointerstitial damage is
becoming easier to explain.
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